Thus, in contrast to what is observed in obesity and diabetes, high levels of FGF21 in healthy aging are not associated with repressed FGF21‐responsiveness machinery in adipose tissue. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.